An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important ...

Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...

Absent much drama, Wednesday's National Signing Day was a celebration of the work programs have done to assemble top-ranked classes. The Early Signing Period's Wednesday start (Dec. 3-5) formally ...

Curi Bio’s ribbon cutting in April 2025 for its new headquarters on Seattle’s waterfront. Elliot Fisher, co-founder and chief business officer, cuts the ribbon with a sword while CEO Nicholas Geisse ...

ICSE Biology Specimen Paper 2026 for Class 10: The ICSE Biology Specimen Paper 2026 exam will be held on 13 March 2026, and students appearing for the CISCE Class 10 Board Exam are highly encouraged ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

Upstream Bio (UPB) shares have climbed over 10% today, drawing attention from market watchers. The move adds to the company’s strong performance over the past month and has sparked curiosity about ...

Abstract: Continuous monitoring of fluid status through bioimpedance (Bio-Z) measurement of thoracic magnitude or phase is critical in reducing the mortality of chronic heart failure (CHF) patients.

We report the crystal structure of a class D β-lactamase, the broad spectrum enzyme OXA-10 from Pseudomonas aeruginosa at 2.0 Å resolution. There are significant differences between the overall fold ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new Cambridge biotech company ...

Nabla Bio and Takeda's collaboration focuses on AI-driven protein therapeutics, leveraging the Joint Atomic Model (JAM) platform for de novo antibody design across early-stage programs. Nabla Bio is ...

From startups to giants in pharma and tools, the use of spatial biology is growing in importance in drug discovery. LatchBio, a four-year-old San Francisco builder of software and data infrastructure ...